Stocks and Investing
Stocks and Investing
Wed, September 25, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Nicole Germino Initiated (catx) at Strong Buy and Held Target at $21 on, Sep 25th, 2024
Nicole Germino of Truist Securities, Initiated "Perspective Therapeutics, Inc." (CATX) at Strong Buy and Held Target at $21 on, Sep 25th, 2024.
Nicole has made no other calls on CATX in the last 4 months.
There are 4 other peers that have a rating on CATX. Out of the 4 peers that are also analyzing CATX, 0 agree with Nicole's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Nicole
- Louis Chen of "Cantor Fitzgerald" Reiterated at Buy on, Tuesday, September 10th, 2024
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $27 on, Friday, August 16th, 2024
- Jeff Jones of "Oppenheimer" Maintained at Buy with Decreased Target to $17 on, Tuesday, August 13th, 2024
- Alec Stranahan of "B of A Securities" Initiated at Strong Buy and Held Target at $24 on, Thursday, July 25th, 2024
Contributing Sources